Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Traws Pharma, Inc. | 96,899 | reported | 08 Mar 2026 | tx 17+6,936,964.1−607,794.75 |
| Venetian-1 Acquisition Corp. | 0 | reported | 01 Nov 2024 | tx 6+5,168,762 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Mar 2026 | GRANT_AWARD | Traws Pharma, Inc. | 96,899 | 0.00 USD | deriv |
| 12 Dec 2025 | GRANT_AWARD | Traws Pharma, Inc. | 16,419 | 0.00 USD | |
| 12 Dec 2025 | GRANT_AWARD | Traws Pharma, Inc. | 65,676 | 0.00 USD | deriv |
| 12 Oct 2025 | GRANT_AWARD | Traws Pharma, Inc. | 22,435 | 0.00 USD | deriv |
| 02 Apr 2025 | OTHER | Traws Pharma, Inc. | 605,531 | — | |
| 02 Apr 2025 | OTHER | Traws Pharma, Inc. | 2,263.75 | 0.00 USD | deriv |
| 29 Dec 2024 | PURCHASE | Traws Pharma, Inc. | 96,348 | — | deriv |
| 29 Dec 2024 | PURCHASE | Traws Pharma, Inc. | 96,348 | — | deriv |
| 01 Nov 2024 | CONVERSION | Venetian-1 Acquisition Corp. | 539,062 | 3.20 USD | |
| 01 Nov 2024 | CONVERSION | Venetian-1 Acquisition Corp. | 694,444 | 3.60 USD | |
| 01 Nov 2024 | GRANT_AWARD | Venetian-1 Acquisition Corp. | 1,443,750 | 4.00 USD | |
| 01 Nov 2024 | GRANT_AWARD | Venetian-1 Acquisition Corp. | 1,258,000 | 0.00 USD | deriv |
| 01 Nov 2024 | CONVERSION | Venetian-1 Acquisition Corp. | 539,062 | 0.00 USD | deriv |
| 01 Nov 2024 | CONVERSION | Venetian-1 Acquisition Corp. | 694,444 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 885,532 | — | |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 1,645,100 | — | |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 66,687 | — | |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 67,550 | — | |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 194.62 | — | deriv |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 2,584.37 | — | deriv |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 4,801.11 | — | deriv |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 3,802,890 | — | deriv |